Convergent Research creates Focused Research Organizations (FROs) to overcome specific technological bottlenecks in science — the kind that are too big for a single lab, too coordination-intensive for a loose collaboration, and not directly profitable enough for venture capital. We fund and incubate these as nonprofit startups: small, focused teams with concrete build targets, finite timelines, and a mandate to produce tools, datasets, or platforms that transform what's possible in their field. FROs occupy a specific niche in the research landscape that traditional institutions are not positioned to fill.
Each FRO is structured as an independent nonprofit, run by full-time technical founders who oversee a team of roughly 10 to 30 employees. They pursue specific, quantifiable technical milestones over a finite duration — typically 3 to 7 years — with budgets in the range of $15 to $50 million. They are not open-ended research centers or blue-sky exploration vehicles.

FROs are startup-like organizations with a concrete mission: to overcome a particular technological bottleneck and build a well-defined product — a tool, system, dataset, or platform — that seeds an ecosystem and generates what we call a "scaled revolution."
A scaled revolution means something like what happened when the cost of DNA sequencing fell by orders of magnitude: it didn't just help one subfield, it reshaped entire domains of biology, medicine, environmental science, and more. That's the standard we aspire to. Each FRO should aim to produce something so much better along key dimensions — often 10x or more improvement in an underlying capability — that adoption becomes inevitable and the downstream effects cascade broadly across a field or multiple fields.
<aside> 📽️
Video
Here is an excerpt from a Feb 2026 webinar introducing Convergent & FROs:
https://www.youtube.com/watch?v=7F0x9P2kgNM
</aside>
Understanding what an FRO is not is just as important as understanding what it is.
This doesn't take advantage of the FRO's independent nonprofit status and Convergent Research's operational capabilities — for example, the ability to hire engineers or other non-trainee talent at industry wages, or to pursue non-publishable work that wouldn't fit within traditional academic incentive structures. This also often applies to the idea of converting a lab into a broader "institute." Sometimes that can be a great thing to do, but it isn't an FRO.
This fails to leverage multidisciplinary hiring opportunities or the startup-like organizational structure and laser focus on time-bounded milestones to unlock a very specific bottleneck that FROs emphasize. The value of an FRO comes from directed, coordinated effort — not simply co-location of talented individuals. Just getting a bunch of good people together in the same institution is not a FRO. We need concrete deliverables that require tight engineering coordination to achieve.
FROs exist to catalyze problems getting solved — and that is not always the same as directly working on the biggest problem. FROs are justified not by the raw value of their output but by their comparative advantage: doing things academia and industry cannot do.
For example, if the biggest problem in transcranial ultrasound stimulation is identifying its mechanism of action, the right FRO project might be to build hardware, establish experimental protocols, and distribute them to labs so those labs can figure out the mechanism. FROs often do work on some of the greatest direct challenges in a field, but that should not be assumed by default.